Crohn’s & Colitis Foundation: IBD Innovate (New York City, Oct 2026)
Steven St. Peter, MD, Co-Founder and Managing Director of Vie Ventures, delivered a keynote address at IBD Innovate 2026. His discussion explored how different sources of capital can help translate scientific discoveries into new therapies for people living with inflammatory bowel disease and other autoimmune diseases.
In this highlight, Steven explains the complementary roles of venture philanthropy, impact investing and conventional biotech venture capital. Each serves a different purpose, and all three can support the same company at the same time. None replaces the others, and there does not need to be a sequential handoff from one model to another.
He also recognizes the contribution of the Crohn’s & Colitis Foundation’s IBD Ventures program, which brings together capital, disease expertise and connections to the patient community. The aim is to expand the ways patients, families and investors can participate in therapeutic development while strengthening the work already underway.
Watch the highlight below.
- Watch the full keynote and Q&AComing soon
- View the presentation slidesComing soon
- Read the transcriptComing soon
From a keynote address at the Crohn’s & Colitis Foundation’s IBD Innovate conference; video provided by the Foundation.
All news
